The effect of MYCN-MAX on tumor growth coupled with the observation that GD2 is able to enhance angiogenesis [93], thereby increasing the supply of blood borne nutrients needed by proliferating tumor cells, supports the hypothesis that they act synergistically to enhance/maintain cell growth. Here, MYCN is linked to neoplasm.